(iv) AIM2 inflammasome activation and atherogenic proinflammatory factor interleukin-1β (IL-1β) and interleukin-18 (IL-18) release promote inflammatory responses of atherosclerosis [7, 12]. This evidence concerns the gene AIM2 and atherosclerosis.